Detection and Quantitation of Cytomegalovirus DNA in Plasma from Patients with Cytomegalovirus Pneumonia
-
- TOKIMATSU Iseei
- Second Department of Internal Medicine, Oita Medical University
-
- TASHIRO Takayoshi
- The School of Allied Medical Sciences, Nagasaki University
-
- YAMAKAMI Yuriko
- Second Department of Internal Medicine, Oita Medical University
-
- YAMASAKI Tohru
- Second Department of Internal Medicine, Oita Medical University
-
- NAGAOKA Hiroshi
- Second Department of Internal Medicine, Oita Medical University
-
- NAGAI Hiroyuki
- Second Department of Internal Medicine, Oita Medical University
-
- HASHIMOTO Atsuro
- Second Department of Internal Medicine, Oita Medical University
-
- GOTO Yoichiro
- Second Department of Internal Medicine, Oita Medical University
-
- SABURI Yoshio
- Second Department of Internal Medicine, Oita Medical University
-
- KIKUCHI Hiroshi
- Blood Transfusion Service, Oita Medical University
-
- NASU Masaru
- Second Department of Internal Medicine, Oita Medical University
Bibliographic Information
- Other Title
-
- サイトメガロウイルス肺炎患者の血漿中ウイルスDNAのPCR法による検出と定量化
- サイトメガロ ウイルス ハイエン カンジャ ノ ケッショウチュウ ウイルス D
Search this article
Abstract
Detection and semiquantitation of cytomegalovirus (CMV) DNA in plasma from 17 immunocompromised patients with CMV pneumonia diagnosed histopathologically, 15 CMVseropositive patients without CMV pneumonia and 24 CMV-seropositive healthy volunteers were evaluated, using the polymerase chain reaction (PCR).<BR>CMV DNA was detected in plasma from all of 17 patients with CMV pneumonia, from 1 of 15 patients without CMV disease, but from none of healthy volunteers. One patient without CMV disease exhibited positive CMV DNA by PCR 2 days before death. Plasma CMV DNA was negative at the time of admission in all patients, however, it became positive 1-28 days (mean, 14 days) before the onset of CMV pneumonia in 16 patients. The amount of viral DNA in plasma were 103-105 copies/ml (mean, 104.0 copies/ml) when first detected by PCR. At the onset of CMV pneumonia, they were 104-106 (mean, 105.3 copies/ml), and increased with disease progression and decreased with disease improvement because of treatment with antiviral agents.<BR>We succeeded in detection of CMV DNA in plasma before the development of CMV pneumonia, and showed the amount of viral DNA reflected the extent of active CMV pneumonia. Thus, PCR amplification of CMV DNA in plasma is a useful tool for early diagnosis and monitoring of immunocompromised patients.
Journal
-
- Kansenshogaku Zasshi
-
Kansenshogaku Zasshi 69 (9), 963-968, 1995
The Japanese Association for Infectious Diseases
- Tweet
Details 詳細情報について
-
- CRID
- 1390282680022326144
-
- NII Article ID
- 130004330413
- 10008727081
-
- NII Book ID
- AN00047715
-
- ISSN
- 1884569X
- 03875911
-
- NDL BIB ID
- 3644791
-
- PubMed
- 7594796
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed